Probiotic supplementation to support gut health, immune response, and well-being in adults
Official title: Randomized, Double-Blind, Placebo-Controlled Exploratory Study Assessing the Effects of Probiotic Supplementation on Gut Barrier Function, Immune Response, and Well-Being.
Run by Orthomol Pharmazeutische Vertiebs GmbH · NCT07779265 · Data updated 2026-11-12
In this 8-week study, healthy adults with mild to moderate stress will take a probiotic supplement or placebo daily to see if it affects gut barrier function, immune markers, and well-being.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Orthomol Pharmazeutische Vertiebs GmbH Industry-sponsored |
| Locations | 1 site (Trier) |
| Status | Recruiting |
| Started | August 13, 2026 |
| Main results expected | December 2026 |
| Study ends | December 2026 |
| Registry record updated | August 21, 2026 |
| Trial ID | NCT07779265 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are healthy adults 18–65 with mild to moderate perceived stress who are able to comply with study procedures and do not have exclusionary gastrointestinal or neurological/psychiatric conditions.
✕Probably not a fit
Individuals with certain gut disorders, uncontrolled health conditions, or intolerance/allergy to probiotic ingredients may not experience benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a randomized, double-blind, placebo-controlled, single-center study enrolling 50 adults aged 18–65 with mild to moderate perceived stress. Participants will be assigned to probiotic capsules or matching placebo for 56 days, with a 1-week run-in period and visits at screening, pre-intervention, and post-intervention. Biological samples (blood and stool) will be analyzed for gut barrier markers, intestinal inflammation, microbiome composition, short-chain fatty acids, and immune function, alongside questionnaires on stress, quality of life, mood, and digestive symptoms. Safety monitoring will include adverse events and vital signs throughout the study.
Why it matters
Potential benefit: If successful, the probiotic could support better gut health, immune markers, and well-being in stressed adults.
How similar studies have gone: Previous research in probiotics has shown mixed but promising effects on gut function and immune markers, making this exploratory study important to explore potential benefits.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Volunteer is healthy at the time of screening according to participant's own statements. * TICS SSCS score ≥ 6. * Male or female aged ≥18 and ≤65 years at the time of screening. * BMI ≥18.5 and ≤29.9 kg/m². * Volunteer is able and willing to comply with the study instructions. * Volunteer is suitable for participation in the study according to the investigator/study personnel. * Voluntary, written informed consent to participate in the study. Exclusion Criteria: * No command of local language. * Currently diagnosed neurological or psychiatric disorders. * Gastrointestinal disorders including irritable bowel syndrome (IBS), inflammatory bowel disease (IBD) or other conditions that might affect the gut environment. * Contraindication or allergy to any ingredient in the verum or Placebo product. * Use of drugs in the previous 4 weeks before the beginning of intervention. * Use of laxatives and labelled pre#and probiotics in the previous 2 weeks before the beginning of intervention. * Participation in another study with any investigational product within 30 days of screening, or less than five elimination half-lives after the last administration of the investigational product (whichever period is longer) or during the study. * History of drug (recreational) or alcohol abuse. * Bowel preparation for investigative procedures in the 4 weeks prior to screening. * Surgical resection of any part of the bowel (excl. appendectomy). * Pregnant or lactating female, or pregnancy planned during study period, or women of childbearing potential who are not using a medically approved form of contraception (at least three months prior to screening). * Regular smoking.
Where it's running
-
daacro GmbH & Co.KG
Trier, Germany Recruiting
Study contacts
- Study coordinator: Juliane Hellhammer, PhD
- Email: hellhammer@daacro.de
- Phone: +49 651 9120 494
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Overnight Temperature Regulation to Test Gut Health, Inflammation, and Circadian Rhythms
This study tests whether two weeks of using the Eight Sleep Pod at night can improve gut bacteria balance, lower inflammation, and strengthen daily temperature and blood pressure rhythms in postmenopausal women and age-matched men with poor sleep.
-
Egg intake and gut health, HDL, and immune markers in adults
This study tests whether daily egg whites or whole eggs affect gut microbiome, HDL function, metabolism, and immune profiles in adults with a range of BMIs.
-
Tiny Tummies: Milk vs. Oat Milk for Toddlers
This 12‑month randomized study will test whether 12‑month‑old toddlers who drink daily cow’s milk dairy vs. oat milk dairy have better growth, sleep, neurocognitive outcomes, and gut microbiome by 24 months.
-
Combining 10-day Fasting with Fibre to Boost Gut Health
This study tests whether adding dietary fibre to a 10-day fast improves gut microbiome function and metabolic health in adults with overweight or obesity.
-
Daily kefir during mid-pregnancy to see if it helps prevent gestational diabetes
Pregnant people will drink kefir daily from mid-pregnancy to see if it improves blood sugar and insulin, reduces gestational diabetes risk, and positively affects gut bacteria.
-
Personalized binaural and spatial music to help with dementia-related symptoms
This study tests whether personalized binaural beat music, spatialized music, or both can help reduce behavioral and mood symptoms in older adults with dementia or age-related changes living in assisted living facilities.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.